[HTML][HTML] A novel coronavirus from patients with pneumonia in China, 2019

…, F Zhan, X Ma, D Wang, W Xu, G Wu… - New England journal …, 2020 - Mass Medical Soc
In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a
seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was …

[HTML][HTML] A novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019− 2020

…, X Ma, W Wang, P Niu, W Xu, GF Gao, G Wu - China CDC …, 2020 - weekly.chinacdc.cn
… Corresponding authors: Wenjie Tan, tanwj@ivdc.chinacdc.cn; Guizhen Wu, wugz@ivdc.chinacdc.cn …
Guizhen WuGuizhen Wu, wugz@ivdc.chinacdc.cn …

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

R Lu, X Zhao, J Li, P Niu, B Yang, H Wu, W Wang… - The lancet, 2020 - thelancet.com
Background In late December, 2019, patients presenting with viral pneumonia due to an
unidentified microbial agent were reported in Wuhan, China. A novel coronavirus was …

[HTML][HTML] A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

…, Z Chen, P Liu, J Song, T Song, X Bi, C Han, L Wu… - Nature, 2020 - nature.com
An outbreak of coronavirus disease 2019 (COVID-19) 1 , 2 – 3 , caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) 4 , has spread globally. Countermeasures …

Detection of SARS-CoV-2 in different types of clinical specimens

W Wang, Y Xu, R Gao, R Lu, K Han, G Wu, W Tan - Jama, 2020 - jamanetwork.com
Methods| We investigated the biodistribution of SARS-CoV-2 among different tissues of
inpatients with coronavirus disease 2019 (COVID-19) diagnosed based on symptoms and …

[HTML][HTML] Human infection with a novel avian-origin influenza A (H7N9) virus

…, J Han, H Yu, D Li, GF Gao, G Wu… - … England Journal of …, 2013 - Mass Medical Soc
Background Infection of poultry with influenza A subtype H7 viruses occurs worldwide, but the
introduction of this subtype to humans in Asia has not been observed previously. In March …

[HTML][HTML] Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

…, H Wang, Y Yang, GF Gao, W Tan, G Wu… - The Lancet infectious …, 2021 - thelancet.com
Background The ongoing COVID-19 pandemic warrants accelerated efforts to test vaccine
candidates. We aimed to assess the safety and immunogenicity of an inactivated severe …

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2

…, P Cui, J Wang, X Zhang, Y Guan, W Tan, G Wu… - Science, 2020 - science.org
Severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) causes the infectious
disease COVID-19 (coronavirus disease 2019), which was first reported in Wuhan, China, in …

[HTML][HTML] Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2

…, S Yu, Z Zhang, G Xu, C Li, Z Lou, M Xu, C Qin, G Wu… - Cell, 2020 - cell.com
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) threatens global public health. The development of a …

[HTML][HTML] The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

…, M Yang, J Han, W Xu, W Tan, X Peng, Q Jin, G Wu… - Nature, 2020 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of coronavirus
disease 2019 (COVID-19), which has become a public health emergency of international …